IAU Percutaneous Nephrolithotripsy Study

Recruiting Observational Study
Urolithiasis Kidney Calculi
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 100
Sex
Any
Study type
Observational
Participants needed
4,000 (estimated)
Sponsor
Foundation Endourology · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
During the past 10-15 years, important advancements have been witnessed in percutaneous nephrolithotomy (PCNL) techniques and instrumentation. The development of miniaturized PCNL techniques and modern laser technologies has contributed to lower complication rates, alongside changes in exiting strategies and postoperative drainage protocols. Ultrasound is increasingly utilized to create percutaneo…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patient age 18 years or older at the time of enrollment. * Diagnosed with single or multiple renal calculi (including complex and staghorn calculi) or proximal ureteral stones. * Scheduled to undergo any primary or secondary percutaneous surgical stone intervention, including …
Contacts

Iliya P Saltirov, DSc

+359888723744

iliya.saltirov@gmail.com

CONTACT

Ognyan H Gatsev, PhD

+359883490750

gatsev@gmail.com

CONTACT